Two-way interactions between inflammation and coagulation, Trends Cardiovasc Med, vol.15, pp.254-259, 2005. ,
The impact of the inflammatory response on coagulation, Thromb Res, vol.114, pp.321-327, 2004. ,
Thrombin and phenotypic modulation of the endothelium, Arterioscler Thromb Vasc Biol, vol.24, pp.41-53, 2004. ,
Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2, Blood, vol.108, pp.1868-1876, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-01595821
Membrane microparticles: two sides of the coin, Physiology, vol.20, pp.22-27, 2005. ,
In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant, J Clin Invest, vol.104, pp.93-102, 1999. ,
Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity, Blood, vol.99, pp.3962-3970, 2002. ,
Activation of plasminogen into plasmin at the surface of endothelial microparticles, Blood, vol.110, pp.2432-2439, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-00160595
Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells, Am J Pathol, vol.160, pp.673-680, 2002. ,
Type 1 and type 2 diabetic patients display different patterns of cellular microparticles, Diabetes, vol.51, pp.2840-2845, 2002. ,
Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome, Thromb Haemost, vol.91, pp.667-673, 2004. ,
Elevation of circulating endothelial microparticles in patients with chronic renal failure, J Thromb Haemost, vol.4, pp.566-573, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-01610442
Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes, Blood, vol.102, pp.2678-2683, 2003. ,
Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes, Int J Cardiol, vol.97, pp.439-446, 2004. ,
Endothelial dysfunction in uterine circulation in preeclampsia, Am J Obstet Gynecol, vol.187, pp.1608-1616, 2002. ,
TRAIL: a multifunctional cytokine, Front Biosc, vol.12, pp.3813-3824, 2007. ,
The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology, Cytokine Growth Factor Rev, vol.17, pp.245-257, 2006. ,
Following a TRAIL: update on a ligand and its five receptors, Cell Res, vol.14, pp.359-372, 2004. ,
Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing Ligand, J Biol Chem, vol.280, pp.40599-40608, 2005. ,
Phenotypic heterogeneity of the endothelium, Circ Res, vol.100, pp.158-173, 2007. ,
The direct thrombin inhibitor hirudin, Thromb Haemost, vol.99, pp.819-829, 2008. ,
TNF-{alpha}, and LPS exert overlapping but nonidentical effects on gene expression in endothelial cells and vascular smooth muscle cells, Am J Physiol Heart Circ Physiol, vol.289, pp.873-885, 2005. ,
The tumor necrosis factor-related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation, J Biol Chem, vol.275, pp.32208-32213, 2000. ,
Differential activation of TRAIL-R1 and-2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative, Oncogene, vol.20, pp.4101-4106, 2001. ,
FADD is required for DR4-and DR5-mediated apoptosis, J Biol Chem, vol.275, pp.25065-25068, 2000. ,
TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-B, Immunity, vol.7, pp.831-836, 1997. ,
The death domain kinase RIP mediates the TNF-induced NF-kappa B signal, Immunity, vol.8, pp.297-303, 1998. ,
Modulation of tumor necrosis factor apoptosis-inducing ligand-induced NF-kappa B activation by inhibition of apical caspases, J Biol Chem, vol.276, pp.34743-34752, 2001. ,
TRAIL and NFB signaling-a complex relationship, Vitam Horm, vol.67, pp.103-132, 2004. ,
Thrombin activates nuclear factor-kappaB and potentiates endothelial cell activation by TNF, J Immunol, vol.159, pp.5620-5628, 1997. ,
Thrombin induces endothelial type II activation in vitro, J Immunol, vol.158, pp.5435-5441, 1997. ,
TRAIL induces apoptosis and inflammatory gene expression in human endothelial cells, J Immunol, vol.171, pp.1526-1533, 2003. ,
cFLIPL inhibits tumor necrosis factor-related apoptosis-inducing ligand-mediated NF-kappaB activation at the death-inducing signaling complex in human keratinocytes, J Biol Chem, vol.279, pp.52824-52834, 2004. ,
Following the TRAIL to apoptosis, Immunol Res, vol.35, pp.249-262, 2006. ,
TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways, Circulation, vol.107, pp.2250-2256, 2003. ,
Evidence for a proangiogenic activity of TNFrelated apoptosis-inducing ligand, Neoplasia, vol.6, pp.364-373, 2004. ,
Activated protein c decreases tumor necrosis factor-related apoptosis-inducing ligand by an EPCR-Independent mechanism involving Egr-1/Erk-1/2 activation, Arterioscler Thromb Vasc Biol, vol.27, pp.2634-2641, 2007. ,
Apoptotic phenotype alters the capacity of tumor necrosis factor-related apoptosis-inducing ligand to induce human vascular endothelial activation, J Vasc Res, vol.45, pp.111-122, 2007. ,
, TRAIL and vascular injury. Front Biosc, vol.12, pp.3656-3667, 2007.
Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus, Ann Rheum Dis, vol.64, pp.854-858, 2005. ,
Endotoxin increases plasma soluble tumor necrosis factor-related apoptosis-inducing ligand level mediated by the p38 mitogen-activated protein kinase signaling pathway, Shock, vol.22, pp.186-188, 2004. ,
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt, J Biol Chem, vol.280, pp.15709-15718, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-02262258
Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism, Arthr Rheum, vol.46, pp.2857-2866, 2002. ,
Levels of endothelial and platelet microparticles and their interactions with leukocytes negatively correlate with organ dysfunction and predict mortality in severe sepsis, Crit Care Med, vol.33, pp.2540-2546, 2005. ,
Microparticles in cardiovascular diseases, Cardiovasc Res, vol.59, pp.277-287, 2003. ,
Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques, Circulation, vol.99, pp.348-353, 1999. ,
Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques, J Am Coll Cardiol, vol.49, pp.772-777, 2007. ,
Expression, regulation and function of trail in atherosclerosis, Biochem Pharmacol, vol.75, pp.1441-1450, 2008. ,
The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis, J Am Coll Cardiol, vol.45, pp.1018-1024, 2005. ,
Osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in atherosclerosis, Atherosclerosis, vol.184, pp.446-447, 2006. ,